C. O'Dowd

556 total citations
15 papers, 436 citations indexed

About

C. O'Dowd is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, C. O'Dowd has authored 15 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in C. O'Dowd's work include Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and Enzyme Catalysis and Immobilization (4 papers). C. O'Dowd is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and Enzyme Catalysis and Immobilization (4 papers). C. O'Dowd collaborates with scholars based in United Kingdom, Switzerland and China. C. O'Dowd's co-authors include Narain D. Sharma, Derek R. Boyd, Christopher C. R. Allen, Gérald Gavory, Timothy Harrison, Jakub Flasz, Oliver Barker, Keeva McClelland, Natalie Page and Matthew Helm and has published in prestigious journals such as Cancer Research, Chemical Communications and Scientific Reports.

In The Last Decade

C. O'Dowd

15 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. O'Dowd United Kingdom 10 333 171 115 55 28 15 436
Jakub Flasz United Kingdom 9 226 0.7× 191 1.1× 107 0.9× 47 0.9× 11 0.4× 11 410
Christopher G. Nasveschuk United States 14 403 1.2× 304 1.8× 98 0.9× 13 0.2× 39 1.4× 24 667
Julia M. Dolence United States 14 402 1.2× 162 0.9× 87 0.8× 21 0.4× 51 1.8× 14 562
Andrew Germain United States 10 126 0.4× 273 1.6× 71 0.6× 27 0.5× 43 1.5× 14 431
Sajiv K. Nair United States 14 202 0.6× 388 2.3× 90 0.8× 14 0.3× 77 2.8× 26 619
Y. Carrasco United States 7 225 0.7× 91 0.5× 56 0.5× 20 0.4× 39 1.4× 10 336
Heiner Fiebig Germany 8 168 0.5× 141 0.8× 112 1.0× 8 0.1× 19 0.7× 10 346
Yu Sha China 13 216 0.6× 116 0.7× 40 0.3× 23 0.4× 15 0.5× 41 388
Richard Versace United States 10 403 1.2× 138 0.8× 275 2.4× 36 0.7× 57 2.0× 20 547
Xingrui He China 13 245 0.7× 117 0.7× 117 1.0× 14 0.3× 19 0.7× 27 444

Countries citing papers authored by C. O'Dowd

Since Specialization
Citations

This map shows the geographic impact of C. O'Dowd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. O'Dowd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. O'Dowd more than expected).

Fields of papers citing papers by C. O'Dowd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. O'Dowd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. O'Dowd. The network helps show where C. O'Dowd may publish in the future.

Co-authorship network of co-authors of C. O'Dowd

This figure shows the co-authorship network connecting the top 25 collaborators of C. O'Dowd. A scholar is included among the top collaborators of C. O'Dowd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. O'Dowd. C. O'Dowd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wappett, Mark, Julien Daubriac, Ian Lobb, et al.. (2024). USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF. Clinical and Translational Medicine. 14(4). e1648–e1648. 9 indexed citations
2.
Page, Natalie, Mark Wappett, C. O'Dowd, et al.. (2022). Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development. Scientific Reports. 12(1). 15715–15715. 8 indexed citations
3.
O'Dowd, C., Gérald Gavory, Tim J. Harrison, et al.. (2019). Abstract 4423: Antitumor activity of the novel oral highly selective Wee1 inhibitor Debio 0123. Cancer Research. 79(13_Supplement). 4423–4423. 5 indexed citations
4.
O'Dowd, C., Matthew Helm, Jakub Flasz, et al.. (2018). Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors. ACS Medicinal Chemistry Letters. 9(3). 238–243. 50 indexed citations
5.
Gavory, Gérald, C. O'Dowd, Matthew Helm, et al.. (2017). Discovery and characterization of highly potent and selective allosteric USP7 inhibitors. Nature Chemical Biology. 14(2). 118–125. 165 indexed citations
6.
Gavory, Gérald, C. O'Dowd, Stephanie G. Burton, et al.. (2016). Abstract LB-159: A novel, potent and selective inhibitor of Wee1 with robust antitumor activity in various cancer xenograph models. Cancer Research. 76(14_Supplement). LB–159. 1 indexed citations
7.
Gavory, Gérald, C. O'Dowd, Keeva McClelland, et al.. (2015). Abstract LB-257: Discovery and characterization of novel, highly potent and selective USP7 inhibitors. Cancer Research. 75(15_Supplement). LB–257. 2 indexed citations
8.
9.
Boyd, Derek R., Narain D. Sharma, John F. Malone, et al.. (2010). Chemoenzymatic synthesis of the carbasugars carba-β-l-galactopyranose, carba-β-l-talopyranose and carba-α-l-talopyranose from methyl benzoate. Organic & Biomolecular Chemistry. 8(6). 1415–1415. 18 indexed citations
10.
Boyd, Derek R., Narain D. Sharma, John F. Malone, et al.. (2010). Chemoenzymatic Synthesis of Carbasugars (+)-Pericosines A−C from Diverse Aromatic cis-Dihydrodiol Precursors. Organic Letters. 12(10). 2206–2209. 49 indexed citations
11.
12.
Boyd, Derek R., et al.. (2006). Chemoenzymatic synthesis of the trans-dihydrodiol isomers of monosubstituted benzenes viaanti-benzene dioxides. Organic & Biomolecular Chemistry. 4(11). 2208–2208. 20 indexed citations
13.
Boyd, Derek R., et al.. (2005). Chemoenzymatic synthesis of carbasugars from iodobenzene. Organic & Biomolecular Chemistry. 3(10). 1953–1953. 31 indexed citations
14.
15.
Boyd, Derek R., et al.. (2000). Enantiopure arene dioxides: chemoenzymatic synthesis and application in the production of trans-3,4-dihydrodiols. Chemical Communications. 2151–2152. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jakub Flasz Breakdown of academic impact, for papers by Christopher G. Nasveschuk Breakdown of academic impact, for papers by Julia M. Dolence Breakdown of academic impact, for papers by Andrew Germain Breakdown of academic impact, for papers by Sajiv K. Nair Breakdown of academic impact, for papers by Y. Carrasco Breakdown of academic impact, for papers by Heiner Fiebig Breakdown of academic impact, for papers by Yu Sha Breakdown of academic impact, for papers by Richard Versace Breakdown of academic impact, for papers by Xingrui He
Rankless by CCL
2026